Mainz Biomed BV (NYSE: MYNZ) — Perfil da empresa, notícias e dados financeiros
Mainz Biomed (NASDAQ:MYNZ) is a dynamic company engaged in developing cutting-edge molecular genetics diagnostic solutions for early disease
Mainz Biomed BV
Mainz Biomed (NASDAQ:MYNZ) is a dynamic company engaged in developing cutting-edge molecular genetics diagnostic solutions for early disease detection and prevention. Mainz Biomed focuses on empowering healthcare professionals and enhancing patient care through innovative diagnostics. Their projects include the development of ColoAlert, a convenient and highly effective early detection test for colorectal cancer, alongside other pipeline products that target various gastrointestinal diseases. The company aims to transform diagnostic processes, making them more accessible and efficient for people worldwide, ultimately improving outcomes and saving lives.
Resumo
Operações
Produtos e/ou serviços de Mainz Biomed BV
- ColoAlert offers highly accurate, non-invasive, and easy-to-use colon cancer detection through advanced DNA technology.
- GenoStrip: This is a platform technology for the detection of pathogens in environments on a molecular genetic basis. It's still in the early stages of development, but has potential applications in various fields including healthcare, food safety, and environmental monitoring.
- PancAlert aims at early detection of pancreatic cancer, utilizing biomarker technology for non-invasive testing.
- Research & Development: Mainz Biomed also conducts research and development for other potential diagnostic solutions, focusing on utilizing known and existing biomarkers for reliable and accessible tests.
equipe executiva do Mainz Biomed BV
- Mr. Guido BaechlerCEO & Executive Director
- Mr. William J. Caragol CPACFO & Senior VP
- Dr. Christopher Von Toerne P.M.P., Ph.D.Chief Operating Officer
- Mr. Stefan ErlachHead of Human Resources
Principais indicadores financeiros
Resultados divulgados pela Mainz Biomed BV, em USD.
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 537,1 mil | -16,1 mi | -16,2 mi | |
| 894 mil | -18,7 mi | -21,7 mi | |
| 895,5 mil | -26,6 mi | -26,3 mi | |
| 529,9 mil | -26,4 mi | -26,5 mi |